Skip to main content
×
×
Home

Initial assessment in the management of adult epistaxis: systematic review

  • M Khan (a1), K Conroy (a2), K Ubayasiri (a3), J Constable (a3), M E Smith (a4), R J Williams (a5), I Kuhn (a6), M Smith (a7) and C Philpott (a8)...
Abstract
Abstract Background:

The initial assessment of epistaxis patients commonly includes: first aid measures, observations, focused history taking, and clinical examinations and investigations. This systematic review aimed to identify evidence that informs how the initial assessment of these patients should be conducted.

Method:

A systematic review of the literature was performed using a standardised methodology and search strategy.

Results:

Seventeen articles were included. Factors identified were: co-morbidity, intrinsic patient factors, coagulation screening and ice pack use. Hypertension and anticoagulant use were demonstrated to adversely affect outcomes. Coagulation screening is useful in patients on anticoagulant medication. Four studies could not be accessed. Retrospective methodology and insufficient statistical analysis limit several studies.

Conclusion:

Sustained ambulatory hypertension, anticoagulant therapy and posterior bleeding may be associated with recurrent epistaxis, and should be recorded. Oral ice pack use may decrease severity and can be considered as first aid. Coagulation studies are appropriate for patients with a history of anticoagulant use or bleeding diatheses.

Copyright
Corresponding author
Address for correspondence: Miss Maha Khan, Department of Otolaryngology, Central Manchester University Hospitals, Peter Mount Building, Oxford Road, Manchester M13 9WL, UK E-mail: maha.khan@doctors.org.uk
References
Hide All
1 Integrate (National ENT Trainee Research Network). Epistaxis 2016: national audit of management. J Laryngol Otol. In press
2 Mcleod RW, Price A, Williams RJ, Smith ME, Smith M, Owens D. Intranasal cautery for the management of adult epistaxis: systematic review. J Laryngol Otol. In press
3 Williams A, Biffen A, Pilkington N, Arrick L, Williams RJ, Smith ME et al. Haematological factors in the management of adult epistaxis: systematic review. J Laryngol Otol. In press
4 Iqbal I, Jones HG, Dawe N, Mamais C, Smith ME, Williams RJ et al. Intranasal packs and haemostatic agents for the management of adult epistaxis: systematic review. J Laryngol Otol. In press
5 Swords C, Patel A, Smith ME, Williams RJ, Kuhn I, Hopkins C. Surgical and interventional radiological management of adult epistaxis: systematic review. J Laryngol Otol. In press
6 Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928
7 Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomised studies (MINORS): development and validation of a new instrument. ANZ J Surg 2003;73:712–16
8 Kristensen VG, Nielsen AL, Gaihede M, Boll B, Delmar C. Mobilisation of epistaxis patients – a prospective, randomised study documenting a safe patient care regime. J Clin Nurs 2011;20:1598–605
9 Beran M, Petruson B. Occurrence of epistaxis in habitual nose-bleeders and analysis of some etiological factors. ORL J Otorhinolaryngol Relat Spec 1986;48:297303
10 García Callejo FJ, Bécares Martínez C, Calvo González J, Martínez Beneyto P, Marco Sanz M, Marco Algarra J. Epistaxis and dabigatran, a new non-vitamin K antagonist oral anticoagulant. Acta Otorrinolaringol Esp 2014;65:346–54
11 Denholm SW, Maynard CA, Watson HG. Warfarin and epistaxis – a case controlled study. J Laryngol Otol 1993;107:195–6
12 Herkner H, Laggner AN, Müllner M, Formanek M, Bur A, Gamper G et al. Hypertension in patients presenting with epistaxis. Ann Emerg Med 2000;35:126–30
13 Smith J, Siddiq S, Dyer C, Rainsbury J, Kim D. Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study. J Laryngol Otol 2011;125:3842
14 Abrich V, Brozek A, Boyle TR, Chyou PH, Yale SH. Risk factors for recurrent spontaneous epistaxis. Mayo Clin Proc 2014;89:1636–43
15 Ando Y, Iimura J, Arai S, Arai C, Komori M, Tsuyumu M et al. Risk factors for recurrent epistaxis: importance of initial treatment. Auris Nasus Larynx 2014;41:41–5
16 Goljo E, Dang R, Iloreta AM, Govindaraj S. Cost of management in epistaxis admission: impact of patient and hospital characteristics. Laryngoscope 2015;125:2642–7
17 Lakhani R, Syed I, Qureishi A, Bleach N. The Wexham Criteria: defining severe epistaxis to select patients requiring sphenopalatine artery ligation. Eur Arch Otorhinolaryngol 2013;270:2039–43
18 Monjas-Cánovas I, Hernández-García I, Mauri-Barberá J, Sanz-Romero B, Gras-Albert JR. Epidemiology of epistaxes admitted to a tertiary hospital. Acta Otorrinolaringol Esp 2010;61:41–7
19 Purkey MR, Seeskin Z, Chandra R. Seasonal variation and predictors of epistaxis. Laryngoscope 2014;124:2028–33
20 Terakura M, Fujisaki R, Suda T, Sagawa T, Sakamoto T. Relationship between blood pressure and persistent epistaxis at the emergency department: a retrospective study. J Am Soc Hypertens 2012;6:291–5
21 Klossek JM, Dufour X, de Montreuil CB, Fontanel JP, Peynègre R, Reyt E et al. Epistaxis and its management: an observational pilot study carried out in 23 hospital centres in France. Rhinology 2006;44:151–5
22 Ibrashi F, Sabri N, Eldawi M, Belal A. Effect of atherosclerosis and hypertension on arterial epistaxis. J Laryngol Otol 1978;92:877–81
24 National Institute for Health and Care Excellence. Anticoagulants including non-vitamin K antagonist oral anticoagulants (NOACs). In: https://www.nice.org.uk/advice/ktt16 [22 June 2017]
25 New oral anticoagulants apixaban (Eliquis), dabigatran (Pradaxa) and rivaroxaban (Xarelto). In: https://www.gov.uk/drug-safety-update/new-oral-anticoagulants-apixaban-eliquis-dabigatran-pradaxa-and-rivaroxaban-xarelto [22 June 2017]
26 McGarry GW, Gatehouse S, Hinnie J. Relation between alcohol and nose bleeds. BMJ 1994;309:640
27 McGarry GW, Gatehouse S, Vernham G. Idiopathic epistaxis, haemostasis and alcohol. Clin Otolaryngol Allied Sci 1995;20:174–7
28 National Institute for Health and Care Excellence. Venous thromboembolism: reducing the risk for patients in hospital (Clinical Guideline CG92). In: https://www.nice.org.uk/guidance/cg92/chapter/1-recommendations [22 June 2017]
29 Teymoortash A, Sesterhenn A, Kress R, Sapundzhiev N, Werner JA. Efficacy of ice packs in the management of epistaxis. Clin Otolaryngol Allied Sci 2003;28:545–7
30 Porter M, Marais J, Tolley N. The effect of ice packs upon nasal mucosal blood flow. Acta Otolaryngol 1991;111:1122–5
31 Thaha MA, Nilssen EL, Holland S, Love G, White PS. Routine coagulation screening in the management of emergency admission for epistaxis–is it necessary? J Laryngol Otol 2000;114:3840
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 7
Total number of PDF views: 38 *
Loading metrics...

Abstract views

Total abstract views: 197 *
Loading metrics...

* Views captured on Cambridge Core between 27th December 2017 - 17th January 2018. This data will be updated every 24 hours.